FREE SHIPPING ON ORDERS OVER $150

metabolic acidosis and glutathione Unexplained in critically ill patients: the role of pyroglutamic acid | Intensive Care Medicine Pyroglutamic acidosis | Deranged Physiology

$21.06

Quantity
- +
Description

The data confirmed its effectiveness as a cupuretic agent, reported in 1956 in the Lancet (his US data) 65 and the American Journal of Medicine (his US and British data)

metabolic acidosis and glutathione Unexplained in critically ill patients: the role of pyroglutamic acid | Intensive Care Medicine Pyroglutamic acidosis | Deranged Physiology

Dis 116, 230237 (2022)

metabolic acidosis and glutathione Unexplained in critically ill patients: the role of pyroglutamic acid | Intensive Care Medicine Pyroglutamic acidosis | Deranged Physiology

Y., Lee C

metabolic acidosis and glutathione Unexplained in critically ill patients: the role of pyroglutamic acid | Intensive Care Medicine Pyroglutamic acidosis | Deranged Physiology

R., Rankin, C

metabolic acidosis and glutathione Unexplained in critically ill patients: the role of pyroglutamic acid | Intensive Care Medicine Pyroglutamic acidosis | Deranged Physiology

doi: 10.3389/fimmu.2024.1381225 155 GaoJLiangYWangL

metabolic acidosis and glutathione Unexplained in critically ill patients: the role of pyroglutamic acid | Intensive Care Medicine Pyroglutamic acidosis | Deranged Physiology

You may also like

recommand products